Research Paper Volume 16, Issue 11 pp 9569—9583
Attenuating bone loss in osteoporosis: the potential of corylin (CL) as a therapeutic agent
Figure 6. Inhibition of mitochondrial function by CL. (A) The JC-1 staining image from BMMs treated with CL under osteoclast induction condition. (B) The membrane potential quantifying of mitochondria. (C) The protein band image of Parkin, DRP1, FIS1, and MFN2. (D) The expression quantifying of Parkin, DRP1, FIS1, and MFN2. The ns, not statistically significant; **P < 0.01; ***P < 0.001; ****P < 0.0001.